<DOC>
	<DOCNO>NCT01873716</DOCNO>
	<brief_summary>This pilot study 9 patient undergoing standard-of-care clinically indicate carotid endarterectomy . The nine patient receive injection Indocyanine green ( ICG ) dose 0.25 mg/kg ( maximum 25 mg ) intravenous bolus . Immediately follow endarterectomy , resect specimen immerse normal saline . Ex vivo fluorescence reflectance imaging ( FRI ) immunohistochemistry perform . The investigator hypothesize compare control , ICG-injected patient demonstrate increase ex vivo microscopic ICG fluorescence signal within area plaque .</brief_summary>
	<brief_title>Indocyanine Green Fluorescence Uptake Human Carotid Artery Plaque</brief_title>
	<detailed_description />
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Carotid Stenosis</mesh_term>
	<mesh_term>Plaque , Atherosclerotic</mesh_term>
	<criteria>Consecutive patient schedule elective carotid endarterectomy Massachusetts General Hospital Age &gt; 18 year age . Signed informed consent . Exclusion criterion : Hemodynamic instability Any history iodide allergy Any history renal failure ( estimate Glomerular Filtration Rate ( eGFR ) &lt; 50 ml/min/1.73 m2 ) Any history liver failure Any history bleed diathesis Any history cerebral vascular accident precede 3 month Pregnant lactating female . Hx seafood allergy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Atherosclerosis</keyword>
	<keyword>Molecular Imaging</keyword>
	<keyword>Vascular Biology</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Fluorescence</keyword>
</DOC>